Rebecca Mister
Overview
Explore the profile of Rebecca Mister including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campbell I, Wetzig N, Ung O, Espinoza D, Farshid G, Collins J, et al.
Breast
. 2023 Jul;
70:70-75.
PMID: 37393644
Background: Sentinel node-based management (SNBM) is the international standard of care for early breast cancer that is clinically node-negative based on randomised trials comparing it with axillary lymph node dissection...
2.
Greenham L, Bennett P, Dansie K, Viecelli A, Jesudason S, Mister R, et al.
Trials
. 2022 May;
23(1):419.
PMID: 35590395
Background: Kidney failure prevalence is increasing worldwide. Haemodialysis, peritoneal dialysis or kidney transplantation are undertaken to extend life with kidney failure. People receiving haemodialysis commonly experience fatigue, pain, nausea, cramping,...
3.
Bubb K, Harmer J, Finemore M, Aitken S, Ali Z, Billot L, et al.
BMJ Open
. 2021 Sep;
11(9):e049858.
PMID: 34588252
Introduction: There is currently only one approved medication effective at improving walking distance in people with intermittent claudication. Preclinical data suggest that the β-adrenergic receptor agonist (mirabegron) could be repurposed...
4.
Wetzig N, Gill P, Espinoza D, Mister R, Stockler M, Gebski V, et al.
Ann Surg Oncol
. 2016 Nov;
24(4):1064-1070.
PMID: 27848050
Purpose: To determine whether the benefits of sentinel-node-based management (SNBM) over routine axillary clearance (RAC) persisted to 5 years. Methods: A total of 1088 women with breast cancer less than...
5.
Simes J, Becattini C, Agnelli G, Eikelboom J, Kirby A, Mister R, et al.
Circulation
. 2014 Aug;
130(13):1062-71.
PMID: 25156992
Background: In patients with a first unprovoked venous thromboembolism (VTE) the risk of recurrent VTE remains high after anticoagulant treatment is discontinued. The Aspirin for the Prevention of Recurrent Venous...
6.
Brighton T, Eikelboom J, Mann K, Mister R, Gallus A, Ockelford P, et al.
N Engl J Med
. 2012 Nov;
367(21):1979-87.
PMID: 23121403
Background: Patients who have had a first episode of unprovoked venous thromboembolism have a high risk of recurrence after anticoagulants are discontinued. Aspirin may be effective in preventing a recurrence...
7.
Stansby G, Mister R, Fowkes G, Roughton M, Nugara F, Brittenden J, et al.
Angiology
. 2011 Jan;
62(2):111-8.
PMID: 21220371
We report a prospective 2-year, multicenter study of patients presenting with intermittent claudication (IC; ankle brachial blood pressure index, ABPI ≤ 0.9). Mean age of the 473 patients enrolled was...
8.
Yu L, Zhu J, Mister R, Zhang Y, Li J, Wang D, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
. 2006 Nov;
34(7):593-7.
PMID: 17081359
Objective: To analyze the current use of reperfusion strategies and the outcomes of patients with ST elevation acute coronary syndromes (ACS) in China. Methods: A total of 518 consecutive patients...
9.
Collins P, Flather M, Lees B, Mister R, Proudler A, Stevenson J
Eur Heart J
. 2006 Aug;
27(17):2046-53.
PMID: 16899475
Aims: Randomized trials have not demonstrated coronary heart disease benefit from hormone replacement therapy (HRT). We hypothesized that low-dose HRT may avoid harm. Methods And Results: We studied the effects...
10.
Khan N, De Souza A, Mister R, Flather M, Clague J, Davies S, et al.
N Engl J Med
. 2004 Jan;
350(1):21-8.
PMID: 14702424
Background: The effect of the use of coronary-artery bypass surgery without cardiopulmonary bypass and cardiac arrest ("off pump") on graft patency remains uncertain. We undertook a prospective, randomized, controlled study...